Lakefront Biotherapeutics
LKFT
30.00
+0.68
+2.32%
Lakefront Biotherapeutics
US · LKFT
#2803 by market cap
Listed 1970
30.00
+0.68
+2.32%
Live - 5344 symbols - heartbeat 69s ago
· 2026-10-08 08:22
Pre-market
29.42
-1.93%
After-hours
30.00
0.00%
Overnight
29.31
-2.30%
- Market cap
- 1.96B
- P/E (TTM)i
- 2.96
- P/Bi
- 0.54
- EPSi
- 5.45
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on LKFT?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Morgan Stanley Maintains Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Maintains Target Price $30Market Newswire · 2026/8/10
-
RBC Capital Initiates Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Announces Target Price $28Market Newswire · 2026/5/13
-
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)TipRanks · 2026/8/10
-
RBC Capital Upgrades Lakefront Biotherapeutics(LKFT.US) to Buy Rating, Raises Target Price to $45Market Newswire · 2026/9/23
-
Morgan Stanley Upgrades Lakefront Biotherapeutics(LKFT.US) to Hold Rating, Raises Target Price to $30Market Newswire · 2026/8/3
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:22:25 · For reference only, not investment advice and not tailored to your situation.